drugset
drugset / Trial / NCT00004399

Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia

NCT00004399 ↗

Completed 2000 enrolled FDA Office of Orphan Products Development University of Utah · collab
RandomizedPrevention

Summary

OBJECTIVES: I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia.

Timeline

Start
1995-09
Primary completion
—
Completion
2000-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified — Intravenous
Subject Nimodipine Small molecule — Oral

Indications

preeclampsia